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Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium that has developed
an increasing resistance to antibiotic drugs. This bacterium is very prevalent in hospitals
but is becoming more prevalent in community-based settings. The goals of this research
are to test the antibiotic sensitivity of two strains of MRSA, discover the proper
disinfectants to use in households and hospital settings, and develop and test antibiotic
derivatives to determine the future of antibiotic use against this bacterium. Research
indicated that each strain was resistant to β-lactam antibiotics as well as other antibiotics.
Each strain tested was unique in its resistance against antibiotics, thus proving there is a
need to evaluate the proper antibiotic treatment given to patients with MRSA infections.
Disinfectants with a low or high pH are more effective than disinfectants with a neutral
pH around 7. When testing antibiotic derivatives, this research indicated that compounds
that are amphipathic and contain electron-withdrawing groups have the greatest toxicity
against MRSA.
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Antibiotic and Disinfectant Resistance of Methicillin-Resistant Staphylococcus aureus
Introduction
Methicillin-resistant Staphylococcus aureus, or MRSA, is a species belonging to
the genus Staphylococcus and the family Staphylococcacea. It is a bacterium that is
capable of surviving in the presence of antibiotics and inducing many illnesses in
humans. Staphylococcus aureus became resistant to Penicillin and Methicillin shortly
after these drugs became available for use as antibiotics (Appelbaum, 2007). Penicillin
was introduced in 1940, and as early as 1942, Staphylococcus aureus was reported to be
resistant to the drug. Shortly after Methicillin was introduced in 1961, Staphylococcus
aureus was documented to be resistant to it as well, yielding what we call today,
Methicillin-resistant Staphylococcus aureus, or MRSA. Reports indicate that MRSA is
not only resistant to Penicillin and Methicillin but also to the whole family of antibiotics
known as β-lactams to which Penicillin and Methicillin belong. Various strains of
MRSA have also been identified with resistance against glycopeptide antibiotics, such as
Vancomycin (Garau, Bouza, Chastre, Gudiol, & Harbarth, 2009).
MRSA is mostly found in hospital environments, but there have been increasing
infections outside the hospital in the community (Klevins, et al 2007). This increasing
trend has generated concern because MRSA has the potential to be lethal. In August
2004, a study found that the main cause for skin infections presented in the emergency
department was Methicillin-resistant Staphylococcus aureus (Moran, Krishnadasan,
Gorwitz, Fosheim, McDougal, Carey, & Talan, 2006). There are two main strains of
MRSA and each has different characteristics than the other. The first is called hospitalacquired MRSA, or HA-MRSA, and the second is called community-acquired MRSA, or
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CA-MRSA. HA-MRSA infections, also known as nosocomial infections, and CAMRSA infections are similar in that both are resistant to all β-lactam antibiotics.
Nosocomial infections tend to be more resistant to antibiotics than CA-MRSA infections.
CA-MRSA is more likely to be susceptible to ciprofloxacin, clindamycin, erythromycin,
and gentamicin (Appelbaum, 2007). It was also found that CA-MRSA is more likely to
be susceptible to trimethoprim-sulfamethoxazole, clindamycin, and fluoroquinolone
(LaPlante, Rybak, Amjad, & Kaatz, 2007).

Figure 1. Parts of the body and illnesses caused by a MRSA infection. MRSA has the
ability of infecting multiple parts of the body, thus producing a variety of illnesses
(Image from Todar, 2008).
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The reason for the differences of these two groups of strains is genetic. CAMRSA infections typically have less resistance against antibiotics, contain a different
subtype of staphylococcal cassette chromosome (SCCmec) IV, and carry a gene known
as Panton-Valentine leukocidin (PVL) (Klevens, Morrison, Nadle, Petit, Gershman, &
Ray, 2007, and Appelbaum, 2007). It is speculated that CA-MRSA infections may be
more virulent than HA-MRSA infections due to the PVL gene. The PVL gene is a gene
that creates Panton-Valentine Leukocidin cytotoxin which is responsible for some skin
lesions as well as necrotizing pneumonia.
HA-MRSA and CA-MRSA infections can cause a multitude of illnesses
depending on where the infection is located, as seen in Figure 1. The infections can
cause anything from a small rash to death. Mostly found in children ages 2 to 5 years
old, impetigo is a skin rash that is highly contagious and often caused by Staphylococcus
aureus (Cole & Gazewood, 2007). This skin rash is simply a topical infection of the
epidermis, the site of the body’s first innate immune defenses. Bullous impetigo, which
is characterized by fluid filled blisters compared to simple rashes on the skin in other
cases of impetigo, is common with Staphylococcus aureus.
In the hospital, MRSA is found to grow more readily as biofilms on the catheters
of dialysis patients, which could lead to urinary tract infections. The bacteria growing in
biofilms on medical devices was found to be much more resistant to antibiotic and
antimicrobial treatment than bacteria that are free living (planktonic bacteria).
Specifically, bacteria living in a biofilm are about 1,000 to 1,500 times more resistant
than planktonic bacteria (Wu, Kusuma, Mond, & Kokai-Kun, 2003). This resistance is
because the bacteria have an increased interaction with each other. Devices that are

MRSA Resistance 7
implanted into individuals such as pace-makers and shunts are also subject to biofilm
formation which can cause infections (Saginur, Denis, Ferris, Aaron, Chan, Lee, &
Ramotar, 2006). MRSA biofilms on pace-makers, prosthetic heart valves, and shunts can
cause endocarditis, which is inflammation of the inside lining of the heart chambers and
heart valves. Because of the difficulty in eliminating a biofilm on a medical device in a
patient, a contaminated device that causes an infection must be removed or replaced.
Although the risk of infection from medical devices and implants is low (between 1% and
7%), infections that occur are serious. Morbidity and mortality can follow, as well as
causing an increased time in the hospital, more surgeries to replace the devices, and
additional costs due to the extra health care involved.
Another condition caused by MRSA is osteomyelitis, which is an infection of the
bone or bone marrow (King & Johnson, 2008). This condition can produce different
symptoms depending on which bones are infected. For example, vertebral osteomyelitis
is the infection of the vertebral column, and can result in neurological symptoms, fever,
and edema. Osteomyelitis can be caused by direct inoculation of bacteria through
surgery or an infection caused by bacteria flowing in the blood, also called bacteremia.
Most children infected with osteomyelitis were found to have strains of MRSA with the
Panton-Valentine Leukocidin (PVL) gene (Bocchini, Hulten, Mason, Gonzalez,
Hammerman, & Kaplan, 2006). The strains with the PVL gene were shown to cause
greater illness through increased systemic inflammation.
MRSA is capable of escaping the body’s immune defenses in a variety of ways.
MRSA releases exotoxins such as α-toxin and β-toxin that are able to lyse cell
membranes (Todar, 2008). This bacterium also has the ability to latch onto the antibody,
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IgG, through its surface protein, protein A. By binding to IgG in a different fashion than
regular antigens, it decreases opsonization and thus phagocytic activity. Normally, IgG
increases phagocytic activity by marking pathogens in the body to be ingested. MRSA
can cause toxic shock by releasing superantigens (Ferry, Thomas, Genestier, Bes, Lina,
Vandenesch, & Etienne, 2005). The superantigens are MRSA enterotoxins and toxic
shock toxins that bind more strongly to parts of T-helper cells, thus causing an abnormal
release of cytokines into the body. This influx of cytokines causes a more systemic
inflammatory response, ultimately resulting in septic shock or toxic shock.
In community settings, MRSA is spread in areas where people live in close
quarters and interact with each other often such as prisons, daycare centers, and schools.
Skin to skin contact can cause MRSA to spread. Staphylococcus aureus exists as normal
flora in the anterior nares, or the external portion of the nose, of all humans (Nicolle,
2006). In hospital settings, MRSA is present due to surviving on biofilms and being
present as normal flora on the hands of hospital employees (Cimiotti, Wu, Della-Latta,
Nesin, & Larson, 2004). Since Staphylococcus aureus exists as normal flora in humans,
the bacteria cannot simply be eliminated from surgery rooms, hospitals, or even in the
community. Careful procedures must be followed in order to avoid contamination of
wound and surgery sites when in the hospital (Humphreys, Grundmann, Skov, Lucet, &
Cauda, 2009).
Hospital-acquired and community-acquired MRSA strains are important to study
in order to prevent illness rather than to just treat it. For this reason, this study examines
the resistance of Methicillin-resistant Staphylococcus aureus against disinfectants,
antimicrobial hand soaps, and a variety of antibiotics. The effectiveness of disinfectants
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allows individuals to decide which cleaning products to use against MRSA. The
disinfectants that are tested in this study range from household cleaners to cleaners used
in surgical operating rooms. Antibiotic sensitivity tests aid in choosing the most effective
antibiotic for recovery.
In addition to testing various disinfectants and known antibiotics, antibiotics that
are not standard are being tested against these strains of MRSA. Imidazole, shown in
Figure 2, Triclosan, shown in Figure 3, and their derivatives were researched. By
combining the ideas and results of this research, more derivatives of Imidazole were
created. The goal is to create compounds that are effective against MRSA.

Figure 2. The molecular structure of Imidazole. Imidazole is used as a base compound
in this research. Benzene rings as well as substitutions are made in order to increase its
bacterial toxicity.

In a study using Imidazole, it was found that the presence of electron withdrawing
groups was essential for antimicrobial activity (Sharma, Narasimhan, Kumar, Judge,
Narang, Clercq, & Balzarini, 2008). This study used Imidazole as the base compound
and attached two benzene rings to the Imidazole. The main base of the compound that
produced positive results had two phenyl rings instead of one. This compound was called
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(substituted phenyl)-[2-(substituted phenyl)-imidazole-1-yl]-methanone. One phenyl ring
also had different substitutions to it while the other phenyl ring had only one substitution
that changed. Antibacterial activity was highest when chlorine was placed in either the
R1 or the R3 position on the phenyl ring and when carboxylic acid was placed in the R1
of the substituted phenyl ring.
Another compound that was studied is Triclosan, also known as 5-chloro-2-(2, 4dichloropheoxy) phenol. Triclosan is an antimicrobial agent used in many households in
mouthwashes, toothpastes, and soaps (Suller & Russell, 2000). It is also found in many
plastics, fabrics, and kitchenware (McMurry, Oethinger, & Levy, 1998). Triclosan is
very important because it is effective against Staphylococcus aureus, a broad range of
both gram-positive and gram-negative bacteria and fungi (Stewart, Parikh, Xiao, Tonge,
& Kisker, 1999).

Figure 3. The molecular structure of Triclosan. Triclosan is an antimicrobial agent
found in many commonly known hygiene products and is also found to be effective
against Methicillin-Resistant Staphylococcus aureus.

Triclosan targets an enzyme that enables fatty acid synthesis in bacteria. The
enzyme is known as enoyl-acyl carrier protein reductase, or ENR (Stewart et al., 1999).
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By inhibiting this enzyme, fatty acid synthesis is disrupted, thus the membrane bilayers
of the bacteria are not created. ENR catalyzes the NADH-dependent reduction of fatty
acids bound to the acyl-carrier protein. More specifically, Triclosan targets the fabI gene.
This gene codes for ENR (McMurry, Oethinger, Levy, 1998). This was determined
through mutations of the gene and then comparing bacterial lipid synthesis of the mutated
genes and wild-type genes (Stewart et al., 1999).
The effectiveness of Triclosan is brought about by its amphipathic characteristic.
Surfactant products were found to have an increased toxicity to bacteria than products
that were nonpolar (Green, Tocoli, Lee, Nihei, & Kubo, I. 2007). In a study, a side chain
of carbon atoms was lengthened to test the toxicity of the compounds. Compounds with
shorter side chains of carbons, and thus more polar, were found to be more toxic to
bacteria. Researchers found that long carbon chains decreased the toxicity of the
compound against bacteria, and that amphipathic molecules increased toxicity of the
compound. Another study showed that electron withdrawing groups such as Clˉ
increased toxicity as well (Sharma, et al, 2008). Another study showed that adding
chlorine to the already chlorinated Triclosan increased its effectiveness. When
comparing and combining these data, an Imidazole derivative that is effective against
MRSA can be created. Since research indicated that chlorine and a phenyl group play
important roles in toxicity, Imidazole can be modified in order to increase bacterial
toxicity.
This study is divided into four areas of interest. The first area includes the
isolation of this bacterium. The second area of interest is antibiotic sensitivity testing in
which the effectiveness of several antibiotics employed by physicians are tested. The
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third area involves testing MRSA against various disinfectants as well as antimicrobial
hand soap. The final area of interest is testing derivatives of Imidazole to create a drug
that is effective against MRSA.
Methods
Isolation of MRSA
The first step in this research is isolating Methicillin-resistant Staphylococcus
aureus from the environment. The bacterium was acquired from Butner Federal Medical
Center at the Butner Federal Prison. Three patients with known MRSA infections were
swabbed with sterile swabs in order to obtain MRSA samples. The swabs were then
collected in agar slants and sealed to prevent contamination of the environment. These
agar slants were placed in biohazard bags to further ensure the prevention of
contamination. The bags were transported to Liberty University and incubated at 37°
Celsius to allow for growth. The second strain of bacteria was obtained by swabbing an
infection from an individual’s foot that was suspected of being caused by MRSA.
After a few days of growth, the bacteria were placed on mannitol-salt agar (MSA)
plates in order to initially select for Staphylococcus bacteria. Mannitol-salt agar plates
contain a salt concentration of 7.5 percent. Most bacteria are not able to survive in such a
high salt concentration, but Staphylococcus aureus is able to survive in up to 15 percent
salt concentrations (Todar, 2008). Staphylococcus aureus is mannitol-salt positive.
Inoculation of MSA plates allowed for the initial isolation by observing which bacteria
used the nutrients from the environment. This nutrient use was indicated by the plate’s
changing of colors from a red pigment to yellow around the bacteria. The color change
indicates a positive pH change and the bacteria is labeled as mannitol-salt positive. Since
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MRSA is known to be resistant to the antibiotic, Oxycillin, MSA plates that contained
Oxycillin in the agar were made to isolate the bacteria further. Bacteria that grew on the
agar and were mannitol-salt positive were used in additional tests. The bacteria that met
the initial requirement of being mannitol-salt positive and Oxycillin-resistant were then
observed for proper pigmentation. Staphylococcus aureus has been classified as having a
yellow pigmentation (Todar, 2008). Staphylococcus aureus is also characterized as
gram-positive and its shape is that of small, spherical clusters, as seen in Figure 4. The
bacteria in this study were subjected to gram staining and observation. Also, trypticase
soy agar (TSA) and blood agar plates were created. TSA plates simply allowed for
growth of the bacteria, while blood agar plates tested whether the bacteria were
hemolytic.

Figure 4. A picture of Staphylococcus aureus under the microscope after gram-staining.
After gram-staining Staphylococcus aureus on a slide, it is noticeable that the bacterium
is gram-positive by its purple appearance, and it is also identifiable as cocci by its
spherical form (Image from Todar, 2008).
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Catalase, oxidase and coagulase tests were performed. Catalase is an enzyme
found in Staphylococcus aureus that enables it to convert hydrogen peroxide into water
and carbon dioxide. The presence of catalase activity was tested by placing hydrogen
peroxide over the bacteria and observing if bubbles were formed. The oxidase test tests
for the presence of cytochrome C oxidase. In this test N,N-Dimethyl-pphenylenediamine is used as a reagent on a paper disk. Bacteria are placed on paper
disks for observation. If the bacteria changes from colorless to a dark color, the oxidase
test is positive. If the bacterium on the disk does not change color, the oxidase test is
negative. Since Staphylococcus aureus is known to produce the enzyme coagulase, a
coagulase test was performed.
Furthermore, because Staphylococcus aureus is characterized as a facultative
anaerobe, the bacteria were placed in an agar deep to test whether it was an anaerobe,
aerobe, or facultative anaerobe. Each test was done at least twice in order to ensure
accuracy and proper identification of the bacteria.
Antibiotic Sensitivity Tests
Antibiotic sensitivity tests for the two MRSA strains were performed by
inoculating trypticase soy agar, or TSA, plates with TSA broth from each MRSA strain
and placing antibiotic discs onto the plates. The broths were created in test tubes
containing trypticase soy broth and bacteria from existing TSA plates. The broths were
incubated at 37° Celsius for one week before being used for the antibiotic sensitivity
tests. When the broths were ready for the antibiotic sensitivity tests, the absorbances of
the broths were measured to ensure that the broth mixture did not have too high of a
concentration of bacteria for the tests.
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Once the absorbances of the broths were measured, 0.2 milliliters of the broth was
spread over the plate in order to allow for uniform growth of the bacteria. Each TSA
plate was split into four sections in order to avoid waste of agar and plates. The plates
were incubated at 37° Celsius for one week before being examined. The antibiotic
sensitivity tests were done twice for the MRSA strain extracted from the individual’s
foot, which will be called MRSA strain 1, and three times for the MRSA strain acquired
from the prison hospital, which will be called MRSA strain 2, in order to have better
accuracy. In the results, the average zone of inhibition of the trials was used. The zone
of inhibition indicated the effectiveness of the product being tested. It was measured in
millimeters from the middle of the disk to the outside edges of bacterial growth. The
diameter of the disks is 8 millimeters. The MRSA were considered susceptible to any
antibiotics with a zone of inhibition greater than 15 millimeters. The antibiotics tested
were Doxycyline, Erythromycin, Vancomycin, Bacitracin, Oxycillin, Kanamycin,
Steptomycin, Isonazid, Tetracycline, Ciprofoxacin, Ampicillin, Cepthlothin,
Trimethoprim-Sulfamethoxazode, and Penicillin. The results to these tests can be found
in Table 4.
Disinfectant Sensitivity Tests
Disinfectants and hand cleaning antimicrobial agents were tested in order to
observe which products are the most effective in eliminating MRSA. The products tested
were obtained from households, Butner Federal Medical Center, and Liberty University.
The disinfectants and solutions used in the experiment include The Works Toilet
Bowl Cleaner, Kaboom Shower, Tub, and Toilet Bowl Cleaner, Hibiclens Clorohexidine
Gluconate solution, Lysol 4 in 1, Rejuvnal HBV, Povidone, which is an iodine scrub,
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Tilex Mold and Mildew, 70% ethanol, and hydrogen peroxide. The disinfectants were
diluted into five different solutions including 100%, 50%, 25%, 12.5%, and 6.25%.

Table 1. Active ingredients of disinfectants. The active ingredients of the disinfectants
determine the effectiveness of the disinfectant and its dilutions.
Active Ingredients of Disinfectants
Disinfectant Active Ingredients
Povidone
Povidone-iodine USP 7.5%
Clorox
Sodium hypochlorite
Hibiclens
Clorohexidine gluconate solution 4.0% w/v
Sodium hypochlorite, ammonia, lye, sulfuric
Kaboom
acid
Grease
Lightning
Sodium hydroxide, 2-butoxyethanol
The Works
Toilet Bowl
Cleaner
Hydrogen chloride, 20%
Lysol 4 in 1 Benzalkonium chloride
Didecyl dimethyl ammonium chloride,
2.54%, and n-Alkyl dimethyl benzyl
Rejuvnal
ammonium chloride, 1.69%
Tilex Mold
and Mildew Benzalkonium cloride

The active ingredients of the disinfectants are listed in Table 1. Active
ingredients are common in multiple cleaners. These include sodium hypoclorite in both
Clorox and Kaboom and benzalkonium cloride in Lysol 4 in 1 and Tilex. The
disinfectants with similar active ingredients should work about the same, with the
exception that the concentration of the active ingredient may increase or decrease the
effectiveness of the antibacterial properties of the disinfectant. The pH of the
disinfectants were also tested and determined by using pH paper. The color on the pH
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paper indicated the pH of the disinfectant or solution. The pH of each disinfectant and
solution is listed in Table 2.

Table 2. pH of the disinfectants and solutions. The pH of the disinfectants and solutions
was determined by using pH paper.
pH of Disinfectants
Disinfectant
pH
Povidone
4.5
Clorox
10
Hibiclens
9.5
Kaboom
2
Grease Lightning
7.5
The Works Toilet Bowl
Cleaner
0
Lysol 4 in 1
8
Rejuvnal
5
Tilex Mold and Mildew
10
Hydrogen Peroxide
4
70% Ethanol
5

The disinfectants were diluted through serial dilutions. Two milliliters of 100%
solution were placed into a tube with two milliliters of deionized water and mixed. Two
milliliters of that solution were then placed in another test tube containing two milliliters
of deionized water and mixed. This process was repeated until the last test tube
contained a 6.25% solution. Two milliliters of that solution were discarded due to
keeping with a constant volume of two milliliters for each test tube. Disks of filter paper
with a diameter of about 8 millimeters were placed in the tubes to soak for a few minutes
before placing a disk onto an inoculated TSA plate to test the resistance of the bacteria.
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In order to test the bacteria’s resistance against the disinfectants and solutions, the
bacteria were taken from a previously inoculated TSA plate to create a TSA broth. The
broths were allowed to grow for 48 hours in an incubator at 37° Celsius. When taken out
of the incubator, 0.2 milliliters of broth was used to inoculate each TSA plate for testing.
Before inoculation of the plates, the absorbances of the broths were tested. The broth
was spread over the plate in order to allow for uniform growth of the bacteria. Each TSA
plate was split into four sections. They were labeled according to which disinfectant,
solution, and their respective dilutions to be tested in the quadrants. 48 hours later, the
bacterial growth was observed. Three trials of the disinfectant sensitivity tests were
performed for both strains of MRSA. Tables 5a, 5b, and 5c list the effectiveness of the
disinfectants, the solutions, and their dilutions in the trials. The zone of inhibition
indicated the effectiveness of the product being tested. It was measured in millimeters
from the middle of the disk to the outside edges of bacterial growth.
Antibiotic Derivative Sensitivity Tests
In preparation for testing the Imidazole derivatives against Methicillin-resistant
Staphylococcus aureus, the drug solvents were tested before the derivatives were tested.
This was to ensure that none of the solvents distorted the results from the Imidazole
derivatives. The solvents that were tested were dimethyl sulfoxide (DMSO) and acetone.
Table 6 lists the solvent dilutions that may be used, their dilutions ranging from 100% to
5% solution, and their respective zones of inhibition. The solvent testing was performed
by using 0.2 milliliters of MRSA broth to inoculate a TSA plate. This was to ensure
uniform growth so that results were not distorted in any way. Filter disks were soaked in
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each dilution and then placed on an inoculated TSA plate. The plates were observed 48
hours after inoculation.
The compounds tested were 2-(3-chlorophenyl)-imidazole, 2-(2-chlorophenyl)imidazole, 2-(4-chlorophenyl)-imidazole, 2-(4-phenyl)-imidazole, and 2-(4methyletherphenyl)-imidazole. These compounds were created in the organic chemistry
lab at Liberty University by Caitlin Hubbard. After discovering the best combination of
solvents, the Imidazole derivatives were dissolved using a mixture of 5% DMSO and
10% acetone and then tested. A range of concentrations of the compounds were tested in
which 0.5, 0.1, 0.01, and 0.001 mg/ml solutions of the compounds were created. The
sensitivity tests for each compound were performed in the same manner as the other
sensitivity tests. A TSA plate was inoculated with 0.2 milliliters of broth and a filter disk
soaked with the liquid compound was placed on a TSA plate. The TSA plates were split
into four quadrants representing varying concentrations of the compound being tested.
These quadrants were 0.5, 0.1, 0.01, and 0.001 mg/ml solutions. The plates were
incubated at 37°Celsius for three days and then observed. The zones of inhibition were
measured in millimeters from the middle of the disk to the outside edge of inhibition
where bacteria began to grow. The results can be found in Table 7.
Results and Discussion
Isolation of MRSA
After gram-staining, the bacteria in the study were found to be gram-positive and
existing as small spherical clusters, which is consistent with Staphyloccocus aureus. The
bacteria on the blood agar plates were hemolytic. The bacteria were also catalase
positive, which is indicative of Staphylococcus aureus. The bacteria in this study did not
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change color on the disk, indicating they are oxidase negative. Because Staphylococcus
aureus doesn’t exhibit oxidase activity, this is further evidence that these bacteria are
Staphylococcus aureus. Since Staphylococcus aureus is known to produce the enzyme
coagulase, a coagulase test was performed, and the bacteria in this study tested positive.
Also, when the bacteria were placed in deeps, they grew down and throughout the agar
deeps as well as at the surface of the agar, proving they are each facultative anaerobes. It
is labeled as a facultative anaerobe because it has the ability to survive in environments
with oxygen and in environments without oxygen. Table 3 lists the tests that were
performed in order to verify the bacteria were MRSA. Each test was performed at least
twice for each strain of MRSA.

Table 3. The strains of bacteria were first isolated and subjected through a series of tests
to ensure that they were indeed Methicillin-resistant Staphylococcus aureus.
Isolation Tests
Small, spherical
Shape
clusters
Color
Yellow
Gram-Stain
Positive
Catalase Test
Positive
Oxidase Test
Negative
Coagulase
Test
Positive
Mannitol Salt
Agar (MSA)
Positive
Hemolytic
Positive
Deep
Facultative Anaerobe
Oxycillin
Resistant
Penicillin
Resistant
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Each test result is characteristic of Staphylococcus aureus. Any bacteria that were
not characteristic of MRSA were discarded. MRSA was separated from normal
Staphylococcus aureus through the use of the mannitol-salt agar plates with Oxycillin.
Normal Staphylococcus aureus is susceptible to Oxycillin, while it has been found that
MRSA is resistant to Oxycillin. This is because Oxycillin belongs to the β-lactam family
of antibiotics, which MRSA is resistant. Two strains of bacteria were isolated from these
tests which were then grown on TSA plates and used in the antibiotic sensitivity,
disinfectant sensitivity, and antibiotic-derivative sensitivity tests.
Antibiotic Sensitivity Tests
All tests were positive to be Methicillin-resistant Staphylococcus aureus. Before
the antibiotic sensitivity tests began, the absorbance of each MRSA strain was measured.
MRSA strain 1 was measured at 0.95 absorbance while MRSA strain 2 measured at 0.4
absorbance. In the antibiotic sensitivity tests, it was found that the strains of bacteria
were resistant to Ampicillin and Penicillin, which belong to the β-lactam antibiotic
family. Their resistance to β-lactam antibiotics further confirms that these strains of
Staphylococcus aureus are MRSA strains.
In addition to each strain being resistant to Oxycillin, Ampicillin, and Penicillin,
each strain was also resistant to Sulfamethoxazole-Trimethoprim, Isonazid, and
Bacitracin. The results, which can be found in Table 4, indicate that both strains are
susceptible to Vancomycin, Doxycycline, Streptomycin, Kanamycin, and Tetracycline.
This means that if a patient is infected with these particular strains of MRSA, physicians
could use these antibiotics to eliminate the bacteria. Choosing an appropriate antibiotic is
important because all bacterial strains are different, as indicated by the data. Some
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antibiotics inhibit MRSA growth while others do not. Ciprofloxacin and Erythromycin
are examples in that each antibiotic inhibited the growth of one strain of MRSA, but not
the other.

Table 4. Antibiotic sensitivity tests. Various antibiotics were tested against Methicillinresistant Staphylococcus aureus.

Antibiotic Sensitivity Tests
Zone of Inhibition
(mm)
MRSA
MRSA
Antibiotic
Strain 1
Strain 2
Doxycycline
42
41.3
Ampicillin
0
0
Ciprofloxacin
21
0
Erythromycin
0
25.3
Vancomycin
24
21.3
Streptomycin
40
36
Sulfamethoxazole
Trimethoprim
0
0
Kanamycin
32
27.3
Oxycillin
0
0
Penicillin
0
0
Tetracycline
34
34.7
Isonazid
0
0
Bacitracin
0
0

Examining this data can lead to other hypotheses. In a study, resistance to
Erythromycin was found to expedite the ease of resistance to Clindamycin due to
inducibility (Siberry, Tekle, Carroll, & Dick, 2003). MRSA isolates that were originally
Erythromycin resistant, but Clindamycin susceptible, were discovered to be resistant
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against Clindamycin when subjected to antibiotic treatment with Clindamycin. To
hypothesize that the strain from MRSA strain 2 is susceptible to the antibiotic
Clindamycin would be reasonable due to its susceptibility to Erythromycin. Likewise,
MRSA strain 1 could be resistant to Clindamycin due to its resistance to Erythromycin.
Disinfectant Sensitivity Tests
MRSA is prevalent in both the healthcare and community settings, so it is
important to exercise proper cleaning and sterilization techniques to decrease the chances
of infection. The reason for diluting the disinfectants and solutions was to observe the
effectiveness against the bacteria even in small quantities of active ingredients. Often
disinfectants are used with water or simply diluted while cleaning. The effectiveness of
the diluted concentrations indicates whether this is a safe practice or not. The reasoning
behind testing hydrogen peroxide was to test a possible means of cleaning and getting rid
of MRSA in the wound when infected with MRSA.
Before the disinfectant sensitivity tests began, the absorbances of the broths were
measured. For all six trials of the tests, the broths of each strain had absorbances of
approximately 0.7. Through antibiotic testing in recent research, it was found that
amphipathic and electron-withdrawing compounds had a much higher rate of bacterial
toxicity than non-polar and regular compounds (Sharma et al., 2008). This toxicity may
also play a large role in the effectiveness of disinfectants against bacteria. Many of the
disinfectants were listed as highly basic or highly acidic solutions because of their active
ingredients. This could be indicative that ionization of parts of bacteria could disrupt
structures and/or functions. Examples of compounds that were known to work against
bacteria were compounds that included chlorine, carboxylic acid, or phenyl substituents.
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Amphipathic solutions should be more effective against bacteria because they are
universal solvents. Like dissolves like is a common phrase used in chemistry that applies
to this situation. Being amphipathic, the compound has the ability to dissolve, bind,
and/or disrupt both polar and nonpolar parts of an organism.

Table 5a. Disinfectant sensitivity tests. The resistance of MRSA was tested against
disinfectants. The zones on inhibition indicate the strength of each disinfectant against
MRSA.
Disinfectant Sensitivity Tests
Zone of Inhibition (mm)
Dilution
MRSA Strain MRSA Strain
Disinfectant (%)
1
2
Povidone
100
20.7
23.3
50
16
18
25
11.3
11.3
12.5
6.7
12.7
6.25
8.3
8
Clorox
100
31.3
34.7
50
24.7
27.3
25
19.7
10.7
12.5
13.7
5.3
6.25
10
5.3
Hibiclens
100
42.5
35
50
47
32.6
25
39.3
36
12.5
39.3
33.3
6.25
47.3
30.6
Kaboom
100
37.3
32.7
50
31.3
23.3
25
20
25.3
12.5
15.3
12.7
6.25
6
5.3
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Table 5b. Disinfectant sensitivity tests. The resistance of MRSA was tested against
disinfectants. The zones on inhibition indicate the strength of each disinfectant against
MRSA.
Disinfectant Sensitivity Tests
Zone of Inhibition (mm)
Dilution
MRSA
MRSA
Disinfectant
(%)
Strain 1
Strain 2
Grease
Lightning
100
0
0
50
0
0
25
0
0
12.5
0
0
6.25
0
0
The Works
Toilet Bowl
Cleaner
100
66
68
50
49.3
73.3
25
35.3
40.7
12.5
24.7
20.7
6.25
20.7
18
Lysol 4 in 1
100
42
31.3
50
40
32.7
25
44
37.3
12.5
32.7
31.3
6.25
32.7
32.7
Rejuvnal
100
0
0
50
0
0
25
3.3
0
12.5
0
0
6.25
0
0
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Table 5c. Disinfectant sensitivity tests. The resistance of MRSA was tested against
disinfectants. The zones on inhibition indicate the strength of each disinfectant against
MRSA.
Disinfectant Sensitivity Tests
Zone of Inhibition (mm)
Dilution MRSA
MRSA
Disinfectant
(%)
Strain 1
Strain 2
Tilex Mold and
Mildew
100
43
40.7
50
36.7
35.3
25
16
20.7
12.5
18
3.3
6.25
0
6.7
Hydrogen
peroxide
100
62
47.3
50
70
47
25
23.3
49.3
12.5
26.7
26
6.25
20
13.3
70% ethanol
100
10.7
10.7
50
3.3
9
25
2.7
7.3
12.5
0
3.3
6.25
0
6

As indicated in the trials, some disinfectants and dilutions were and remained
more effective than other disinfectants and their dilutions. Lysol 4 in 1 proved to be the
best disinfectant by maintaining a large zone of inhibition even when diluted to 6.25%.
The active ingredient in Lysol 4 in 1 was benzalkonium chloride. These results were
consistent with Tilex which was very effective even when diluted to 12.5% because the
active ingredient is benzalkonium chloride as well. In addition to the active ingredient
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playing a role in toxicity, the pH of the disinfectant was important as well. As shown,
disinfectants with either a low or high pH were the most effective. For example, The
Works Toilet Bowl Cleaner had a pH of 0, and it was very effective even when diluted to
6.25%.
Although Tilex Mold and Mildew and The Works Toilet Bowl Cleaner are used
in restrooms, they are still important to note because restrooms need be disinfected from
MRSA as well. Lysol 4 in 1 can be used on countertops and other areas making it very
useful against MRSA in the kitchen, on doorknobs, or virtually any surface as long as it is
hard. Most of the disinfectants were very effective even when diluted to 12.5%, but
many of the disinfectants failed to be effective against MRSA when diluted further to
6.25%.
In this study, Greased Lightning and Rejuvnal were not effective. The strains of
MRSA were resistant to these disinfectants. Greased Lightning is used mainly to remove
grease and stains from carpet, clothes, and countertops. Its main purpose is not to
disinfect counters. Rejuvnal is a hospital-grade disinfectant. This disinfectant should
have worked against both strains of MRSA. This study shows that each strain of MRSA
is resistant to Rejuvnal.
Hibiclens, which is an antimicrobial hand soap used by physicians when prepping
for surgery, was highly effective even when diluted to 6.25%. Povidone, which is the
iodine scrub, is used to prep the surgery sites of patients. This antimicrobial scrub proved
effective in the study. It is important to disinfect with antimicrobial agents that are
known to be effective against MRSA considering that MRSA infections can cause a
variety of illnesses based on where an infection is located in the body. Endocarditis,
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urinary tract infections, and osteomyelitis are examples of infections that can be the
results of contamination during a surgery procedure. If surgery sites become infected,
morbidity or mortality can follow.
70% ethanol and hydrogen peroxide were effective against the bacteria as well.
70% ethanol is used in the microbiology lab at Liberty University. It was effective
against MRSA, but not very effective. However, to ensure that MRSA is eliminated in
the environment, 70% ethanol should not be diluted any further than the full
concentration and should not be used sparingly. Hydrogen peroxide proved to be highly
effective against MRSA. Hydrogen peroxide is not used to clean table tops, but has been
known to clean cuts and wounds. This could be a potential chemical used to clean
MRSA infections and to decontaminate surfaces.
Antibiotic Derivative Tests
The compounds exist in solid form. Because of this, they needed to be dissolved
in a solvent that did not affect inhibition. DMSO and acetone were chosen to be the
solvents in this experiment. The results indicated that a solvent consisting of 5% DMSO
and 10% acetone should work without affecting inhibition. The results of the tests can be
found in Table 6. There was no inhibition of either strain of MRSA at 10% acetone and
5% DMSO. The experiment with MRSA strain 1 will need to be completed again
because some of the filter disks were contaminated with a dye called malachite green.
Some dyes affect the inhibition of bacteria, which could have caused these abnormal
results.
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Table 6. Solvent disinfectant tests. In preparation for testing Imidazole derivatives
against MRSA, the solvents were tested first to ensure that they would not affect
inhibition. The asterisks indicate that the filter disks were contaminated with malachite
green.

Solvent
H2O
Acetone
20% Acetone
15% Acetone
10% Acetone
5% Acetone
DMSO
20% DMSO
15% DMSO
10% DMSO
5% DMSO

Zone of Inhibition (mm)
MRSA
MRSA
Strain 1
Strain 2
12*
11.3*
6*
2.7*
0
0
12.7*
3.3*
3.3*
3.3*
0

0
0
0
0
0
0
0
0
0
0
0

The solid compounds were solubilized using the 10% acetone and 5% DMSO
solvents. In addition, some acid or base was added to the solutions in order to fully
dissolve the compounds. The molecular formulas for these compounds can be seen in
Figure 5. The plates were examined after the incubation period, and it was found that all
of the compounds inhibited both strains of MRSA to some degree. The results for the
antibiotic derivative tests can be found in Table 7. The results indicate that the antibiotic
derivatives are resistant even in smaller concentrations. The most effective antibiotic
derivatives were 2-(2-chlorophenyl)-imidazole and 2-(4-chlorophenyl)-imidazole. The
results coincide with the research which indicated that electron withdrawing groups and
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amphipathic properties increase toxicity. This is shown primarily by 2-(4-chlorophenyl)imidazole, which exhibits the most amphipathic characteristics out of the five compounds
that were tested. According to the research studied, this compound should have been the
most effective against MRSA due to its amphipathic characteristics along with the fact
that it contained chlorine. Although 2-(4-chlorophenyl)-imidazole was shown to coincide
with previous research, the other compounds follow the same trend with the exception of
one. The chlorine groups added to the toxicity of the compound to the MRSA. All of the
compounds were polar to some degree, which created an amphipathic characteristic. 2(4-phenyl)-imidazole was the least effective in the group of antibiotic derivatives. This
data is unique because the hypothesis was that 2-(4-methyletherphenyl)-imidazole would
have been less effective due to less polarity.
Since each compound was effective in inhibiting MRSA, further research should
be performed in order to determine if these compounds would be suitable as commercial
antibiotics. The compounds could be tested with additional concentrations to determine
the ideal potency as an effective antibiotic.
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A.

B.

C.

D.

E.
Figure 5. Molecular formulas of the antibiotic derivatives. The formulas shown are the
compounds of the antibiotic derivatives tested in this study. A. is 2-(4-phenyl)imidazole. B. is 2-(4-methyletherphenyl)-imidazole. C. is 2-(2-chlorophenyl)-imidazole.
D. is 2-(3-chlorophenyl)-imidazole. E. is 2-(4-chlorophenyl)-imidazole.
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Table 7. Antibiotic derivative sensitivity test results. The compounds were tested against
MRSA in four concentrations. The results indicated that each compound was effective
against each MRSA strain to some degree.
Antibiotic Derivative Sensitivity Tests
Zone of Inhibition
(mm)
Concentration MRSA
MRSA
Compound
(mg/ml)
Strain 1
Strain 2
2-(3-chlorophenyl)-imidazole
0.5
10
16
0.1
8.3
10
0.01
8
9.7
0.001
5.3
9.3
2-(2-chlorophenyl)-imidazole
0.5
21.7
15.3
0.1
11
9.7
0.01
6.3
9.3
0.001
6.3
8.7
2-(4-chlorophenyl)-imidazole
0.5
16.7
12.7
0.1
5.3
8
0.01
5.7
2.7
0.001
6
6
2-(4-phenyl)-imidazole
0.5
14
9.3
0.1
16.7
8.7
0.01
7.3
10
0.001
3.3
9.3
2-(4-methyletherphenyl)imidazole
0.5
22
14.7
0.1
11
10.7
0.01
12.3
11
0.001
9.7
10

Conclusion
Methicillin-resistant Staphylococcus aureus can be isolated from virtually any
area such as in a house, daycare, or hospital. This is due to being normal flora on human
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beings as well as being resistant to many antibiotics. There are two types of MRSA
strains, each with distinct qualities. Hospital-acquired MRSA is found in the hospital, is
known to be more resistant to antibiotic therapy, and possibly less virulent than
community-acquired MRSA due to its lack of the PVL gene. Even though the chance of
infection of surgery sites, wounds, or implantation of medical devices is very low, MRSA
still poses a risk of prolonged morbidity and increased mortality in recovering patients.
Community-acquired MRSA is found everywhere outside of the hospital, but is most
often found in areas where populations interact in close quarters such as prisons, schools,
and daycares. CA-MRSA is found to be more virulent since it contains the PantonValentine Leukocidin gene.
The antibiotic sensitivity tests revealed that Doxycycline and Streptomycin are the
best antibiotics when treating these strains of MRSA. Vancomycin, Kanamycin, and
Tetracycline were also highly effective against MRSA, but not as effective as
Doxycycline and Streptomycin. Testing individual strains against MRSA is important
when determining the best antibiotic to use, as is exhibited by the uniqueness of the two
strains. MRSA strain 1 was susceptible to Ciprofloxacin but resistant to Erythromycin.
MRSA strain 2 was the opposite in that it was susceptible to Erythromycin but resistant
to Ciprofloxacin. A common factor in each strain of MRSA is their ability to resist βlactams. This characteristic has been found in previous research as well as in this study.
Each strain of MRSA in this study was resistant to antibiotics belonging to the β-lactam
family, as is evidence by the sensitivity tests against Oxycillin, Ampicillin, and Penicillin.
It was found through the disinfectant, antimicrobial hand soap, and solution tests
that many common disinfectants were effective in eliminating MRSA. Lysol 4 in 1 and
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Tilex Mold and Mildew were highly effective against MRSA even when diluted to a
6.25% solution. The disinfectants each used benzalkonium chloride as their active
ingredient. These two disinfectants can be used in households, prisons, schools, and
daycares. The use of these products could prevent the spread of infection from MRSA as
well as reducing the incidence of MRSA in the Emergency Departments of hospitals.
The most commonly identified skin infection is caused by MRSA, so use of these
disinfectants could reduce this statistic. The chemical structure of the active ingredient in
Lysol 4 in 1 and Tilex Mold and Mildew as compared to its effectiveness correlates with
other studies of antibiotics molecules in that chlorine has an active role in the toxicity
against MRSA.
In the hospital setting, Hibiclens is an effective antimicrobial product for
physicians prepping before surgery. This is also a helpful product to use before handling
medical devices that are implanted into patients. Povidone is an effective scrub to prep
patients before surgery. These two products could reduce the risk of infection from
MRSA, thus decreasing morbidity and mortality in patients after surgery.
Research has shown that amphipathic molecules with electron withdrawing
groups increase toxicity of antibacterial agents. Substituting with additional chlorine,
carboxylic acid, or phenyl groups should increase the toxicity of these molecules against
MRSA. The compounds tested in this study were shown to be effective against MRSA.
Two compounds, 2-(2-chlorophenyl)-imidazole and 2-(4-chlorophenyl)-imidazole, were
more polar and more effective than the other three compounds. These results coincide
with previous research. Additional testing of these compounds could lead to the creation
new antibiotics that will be effective against MRSA.
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